EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimal metrics for SUV values using 18F-FDG PET/MRI in patients with drug-resistant epilepsy and verified epileptogenic lesion

Tatiana M. Rostovtseva, Mikhail B. Dolgushin, Rostislav V. Nadelyaev, Andrey V. Dvoryanchikov, Yulia V. Rubleva, Vidzhai M. Dzhafarov, Ilya V. Senko, Elena A. Baranova, Yulia A. Voronkova, Olga I. Patsap, Sergey G. Burd

Annals of Clinical and Experimental Neurology · 30.06.2026 · 20 (2) · 16-25

DOI: 10.17816/acen.1340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Experimental Neurology, online erschienen am 30.06.2026. Verfasst von Tatiana M. Rostovtseva und 10 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy is one of the most common neurological disorders, affecting individuals of all ages. For patients meeting the criteria for drug-resistant epilepsy established by the International League Against Epilepsy (ILAE), surgery is the most effective treatment option. The success of surgical outcomes depends directly on the precise localization of the epileptogenic focus. Positron emission tomography combined with magnetic resonance imaging (PET/MRI) is a novel hybrid diagnostic modality that may improve detection of the epileptogenic zone in complex diagnostic cases, including patients with MRI-negative epilepsy. Detecting the area of 18F-fluorodeoxyglucose (18F-FDG) hypometabolism in the epileptogenic focus is traditionally based on visual analysis; quantitative analysis techniques for hypometabolism in the epileptogenic focus have not been standardized and remain a subject of scientific investigation.

Aim

To determine the optimal calculation metric (uptake index) of quantitative standardized uptake value (SUV) for detecting the epileptogenic focus in patients with drug-resistant epilepsy using brain 18F-FDG PET/MRI. Materials and methods. We retrospectively analyzed data from hybrid 18F-FDG PET/MRI brain studies performed in 10 healthy volunteers and 19 patients with drug-resistant epilepsy in whom the localization of the epileptogenic focus identified on PET/MRI was confirmed by surgical resection or invasive video-EEG monitoring.

Results

The greatest variability in quantitative SUVmax and SUVmean was observed in patients with focal cortical dysplasia (FCD), while moderate variability in semi-quantitative SUVmax and SUVmean was observed in patients with mesial temporal sclerosis (MTS). The smallest reductions in SUVmax were observed in patients with FCD and MTS; for these patients, the SUVmean parameter was the best for localizing the epileptogenic focus. Analysis of brain PET/MRI data from patients with MRI-negative and MRI-positive epilepsy revealed no significant differences in semi-quantitative 18F-FDG metabolism parameters. In the group of patients with temporal lobe epilepsy, lower SUVmax and SUVmean were recorded, which may reflect the normally observed lower 18F-FDG metabolism in the temporal lobes compared to the cortex of other brain regions.

Conclusion

Statistical analysis of quantitative 18F-FDG metabolism parameters in the epileptogenic focus confirmed by invasive methods indicates that the SUVmean parameter is optimal for identifying hypometabolic areas suspicious for the epileptogenic focus, due to its lower standard deviations and more homogeneous values within the sample, particularly in patients with FCD and MTS.

Zitieren

APA

Rostovtseva, T. M., Dolgushin, M. B., Nadelyaev, R. V., Dvoryanchikov, A. V., Rubleva, Y. V., Dzhafarov, V. M., Senko, I. V., Baranova, E. A., Voronkova, Y. A., Patsap, O. I., & Burd, S. G. (2026). Optimal metrics for SUV values using 18F-FDG PET/MRI in patients with drug-resistant epilepsy and verified epileptogenic lesion. Annals of Clinical and Experimental Neurology, 20(2), 16-25. https://doi.org/10.17816/acen.1340

Vancouver

Rostovtseva TM, Dolgushin MB, Nadelyaev RV, Dvoryanchikov AV, Rubleva YV, Dzhafarov VM, et al. Optimal metrics for SUV values using 18F-FDG PET/MRI in patients with drug-resistant epilepsy and verified epileptogenic lesion. Annals of Clinical and Experimental Neurology. 2026;20(2):16-25. doi:10.17816/acen.1340

BibTeX
@article{Rostovtseva2026,
  author = {Rostovtseva, Tatiana M. and Dolgushin, Mikhail B. and Nadelyaev, Rostislav V. and Dvoryanchikov, Andrey V. and Rubleva, Yulia V. and Dzhafarov, Vidzhai M. and Senko, Ilya V. and Baranova, Elena A. and Voronkova, Yulia A. and Patsap, Olga I. and Burd, Sergey G.},
  title = {Optimal metrics for SUV values using 18F-FDG PET/MRI in patients with drug-resistant epilepsy and verified epileptogenic lesion},
  journal = {Annals of Clinical and Experimental Neurology},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {16--25},
  doi = {10.17816/acen.1340}
}
Kostenlos starten →